CY1107500T1 - Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ - Google Patents

Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ

Info

Publication number
CY1107500T1
CY1107500T1 CY20061101651T CY061101651T CY1107500T1 CY 1107500 T1 CY1107500 T1 CY 1107500T1 CY 20061101651 T CY20061101651 T CY 20061101651T CY 061101651 T CY061101651 T CY 061101651T CY 1107500 T1 CY1107500 T1 CY 1107500T1
Authority
CY
Cyprus
Prior art keywords
flumazenil
drug
development
alternative treatment
alcohol addiction
Prior art date
Application number
CY20061101651T
Other languages
English (en)
Inventor
Ibanez Juan Jose Legarda
Original Assignee
Hythiam, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hythiam, Inc. filed Critical Hythiam, Inc.
Publication of CY1107500T1 publication Critical patent/CY1107500T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)

Abstract

Η εφεύρεση αφορά στη χρήση του φλουμαζενίλ στην ανάπτυξη ενός φαρμάκου που χρησιμοποιείται για τη διαδοχική χορήγηση μικρών ποσοτήτων φλουμαζενίλ κατά πυκνά διαστήματα, μέχρις ότου χορηγηθεί μια θεραπευτικά αποτελεσματική ποσότητα για να αντιμετωπισθεί η εξάρτηση από το αλκοόλ.
CY20061101651T 2001-01-17 2006-11-14 Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ CY1107500T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100106 2001-01-17
EP02716090A EP1374952B1 (en) 2001-01-17 2002-01-10 Use of flumazenil in developing a drug for the treatment of alcohol dependence

Publications (1)

Publication Number Publication Date
CY1107500T1 true CY1107500T1 (el) 2013-03-13

Family

ID=8496426

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101651T CY1107500T1 (el) 2001-01-17 2006-11-14 Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ

Country Status (23)

Country Link
US (2) US7348321B2 (el)
EP (1) EP1374952B1 (el)
JP (2) JP2004519461A (el)
KR (1) KR100712570B1 (el)
CN (1) CN1486205A (el)
AT (1) ATE338575T1 (el)
AU (1) AU2002226427B2 (el)
BR (1) BR0206549A (el)
CA (1) CA2433833C (el)
CR (1) CR7049A (el)
CY (1) CY1107500T1 (el)
DE (1) DE60214527T2 (el)
DK (1) DK1374952T3 (el)
ES (1) ES2269661T3 (el)
HK (1) HK1061661A1 (el)
IL (1) IL156798A0 (el)
MX (1) MXPA03006411A (el)
NZ (2) NZ527583A (el)
PT (1) PT1374952E (el)
RU (1) RU2300378C2 (el)
UA (1) UA78199C2 (el)
WO (1) WO2002056964A1 (el)
ZA (1) ZA200305922B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192271A1 (en) 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
US20060172998A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
US20060172996A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
EP1868593A2 (en) * 2005-04-07 2007-12-26 Hythiam, Inc. Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
US20060263304A1 (en) * 2005-05-23 2006-11-23 Halikas James A Method of controlling alcohol intake and reversing alcohol effects
SG183696A1 (en) * 2007-08-06 2012-09-27 Biotie Therapies Inc Medicaments comprising nepicastat for use in treating dependence on a substance
EP2186517A4 (en) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda USE AND METHODS OF USING A SEROTONIN3 (5-HT3) RECEPTOR ANTAGONIST AND CHLORIDE CHANNEL MODULATOR FOR THE TREATMENT OF DRUG OR DRUG ADDICTION OR DEPENDENCE OR CENTER NERVOUS DISORDERS
AU2010215075B2 (en) * 2009-02-20 2015-08-20 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
US8930050B2 (en) * 2009-04-29 2015-01-06 Marine Canada Acquisition Inc. Method and system for increasing or decreasing engine throttle in a marine vessel
US20100280684A1 (en) * 2009-04-29 2010-11-04 Pierre Garon Synchronization of shift and throttle controls in a marine vessel
US8347859B2 (en) * 2009-04-29 2013-01-08 Marine Canada Acquisition Inc. Automatic throttle calibration in a marine vessel
US8387589B2 (en) * 2009-04-29 2013-03-05 Marine Canada Acqusition Inc. Position sensor for an output shaft used in a shift and throttle system
US8406944B2 (en) * 2010-02-10 2013-03-26 Pierre Garon Control system and method for starting and stopping marine engines
US8845490B2 (en) 2010-02-10 2014-09-30 Marine Canada Acquisition Inc. Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
US8182396B2 (en) * 2010-02-10 2012-05-22 Marine Canada Acquisition In.c Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
AU2012221704B2 (en) 2011-02-23 2013-12-05 Coeruleus Ltd. Flumazenil complexes, compositions comprising same and uses thereof
RU2468799C1 (ru) * 2011-08-03 2012-12-10 Общество с ограниченной ответственностью "Урал Крафт" Способ купирования алкогольного абстинентного синдрома посредством блокады бензодиазепиновых рецепторов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
US20030176456A1 (en) * 2001-12-21 2003-09-18 June Harry L. Methods for reducing alcohol cravings in chronic alcoholics
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids

Also Published As

Publication number Publication date
HK1061661A1 (en) 2004-09-30
NZ539400A (en) 2006-04-28
DE60214527D1 (de) 2006-10-19
RU2300378C2 (ru) 2007-06-10
AU2002226427B2 (en) 2006-11-16
PT1374952E (pt) 2006-12-29
NZ527583A (en) 2006-03-31
MXPA03006411A (es) 2004-12-02
CR7049A (es) 2008-02-20
BR0206549A (pt) 2004-02-25
IL156798A0 (en) 2004-02-08
ATE338575T1 (de) 2006-09-15
KR100712570B1 (ko) 2007-05-02
DK1374952T3 (da) 2007-01-02
EP1374952A1 (en) 2004-01-02
US20040092509A1 (en) 2004-05-13
ES2269661T3 (es) 2007-04-01
JP2004519461A (ja) 2004-07-02
EP1374952B1 (en) 2006-09-06
ZA200305922B (en) 2004-08-02
JP2008201796A (ja) 2008-09-04
CN1486205A (zh) 2004-03-31
KR20040020046A (ko) 2004-03-06
UA78199C2 (en) 2007-03-15
RU2003125274A (ru) 2005-01-20
US20080132492A1 (en) 2008-06-05
DE60214527T2 (de) 2007-04-05
US7348321B2 (en) 2008-03-25
CA2433833A1 (en) 2002-07-25
CA2433833C (en) 2009-06-02
WO2002056964A1 (es) 2002-07-25

Similar Documents

Publication Publication Date Title
CY1107500T1 (el) Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ
CY1118651T1 (el) Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη
CY1119369T1 (el) Ιατρικα παρασκευασματα για τη θεραπευτικη αγωγη της ανεπαρκειας της αλφα-γαλακτοσιδασης α
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
CY1106845T1 (el) Χρηση της φλουμαζενιλης για την παρασκευη ενος φαρμακου για την αγωγη της εξαρτησεως απο την κοκαϊνη
JP2006501240A5 (el)
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
CY2009002I1 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
CY1106122T1 (el) Αναστολεις τρανσφepασης φαρνεσυλ πρωτεϊνης για τη θepαπευτικη αντιμετωπιση της νοσου ευepεθιστου εντερου
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
EA200401303A1 (ru) Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
SE0004827D0 (sv) Therapeutic compounds